Fucoidans from marine brown Macroalgae: Isolation, identification, and potential biological activities

Marine Nutraceuticals: Prospects and Perspectives

Volumn , Issue , 2013, Pages 393-435

  Athukorala, Yasantha ^a   Yuan, Yvonne V ^a  

^a RYERSON UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84923623636     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b13904     Document Type: Chapter

References (125)

1. Ajisaka, K., S. Agawa, S. Nagumo et al. 2009. Evaluation and comparison of the antioxidative potency of various carbohydrates using different methods. J. Agric. Food Chem. 57:3102-3107.
2. Alekseyenko, T.V., S.Y. Zhanayeva, A.A. Venediktova et al. 2007. Antitumor and antimetastatic activity of fucoidan, a sulfated polysaccharide isolated from the Okhotsk Sea Fucus evanescens brown alga. Bull. Exp. Biol. Med. 143:730-732.
3. Allemann, I.B. and L. Baumann. 2009. Botanicals in skin care products. Int. J. Dermatol. 48:923-934.
4. Alves, A.P., B. Mulloy, J.A. Diniz, and P.A.S. Mourão. 1997. Sulfated polysaccharides from the egg jelly layer are species-specific inducers of acrosomal reaction in sperms of sea urchins. J. Biol. Chem. 272:6965-6971.
5. Alwayn, I.P., J.Z. Appel, C. Goepfert, L. Buhler, D.K. Cooper, and S.C. Robson. 2000. Inhibition of platelet aggregration in baboons: Therapeutic implications for xenotransplantation. Xenotransplantation 7:247-257.
6. Angstwurm, K., J.R. Weber, A. Segert et al. 1995. Fucoidin, a polysaccharide inhibiting leukocyte rolling, attenuates inflammatory responses in experimental pneumococcal meningitis in rats. Neurosci. Lett. 191:1-4.
7. Angulo, Y. and B. Lomonte. 2003. Inhibitory effect of fucoidan on the activities of crotaline snake venom myotoxic phospholipases A2. Biochem. Pharmacol. 66:1993-2000.
8. Araya, N., K. Takahashi, T. Sato et al. 2011. Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease. Antivir. Ther. 16:89-98.
9. Athukorala, Y., G.N. Ahn, Y.-H. Jee et al. 2009. Antiproliferative activity of sulfated polysaccharide isolated from an enzymatic digest of Ecklonia cava on the U-937 cell line. J. Appl. Phycol. 21:307-314.
10. Athukorala, Y., W.-K. Jung, T. Vasanthan, and Y.-J. Jeon. 2006. An anticoagulative polysaccharide from an enzymatic hydrolysate of Ecklonia cava. Carbohydr. Polym. 66:184-191.
11. Baumann, R. and P. Rys. 1999. Metachromatic activity of betacyclodextrin sulfates as heparin mimics. Int. J. Biol. Macromol. 24:15-18.
12. Béress, A., O. Wassermann, T. Bruhn, and L. Béress. 1993. A new procedure for the isolation of anti-HIV compounds (polysaccharides and polyphenols) from the marine alga Fucus vesiculosus. J. Nat. Prod. 56:478-488.
13. Berteau, O. and B. Mulloy. 2003. Sulfated fucans, fresh perspectives: Structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. Glycobiology 13:29-40.
14. Bilan, M.I., A.A. Grachev, A.S. Shashkov, N.E. Nifantiev, and A.I. Usov. 2006. Structure of a fucoidan from the brown seaweed Fucus serratus L. Carbohydr. Res. 341:238-245.
15. Bilan, M.I., A.A. Grachev, N.E. Ustuzhanina, A.S. Shashkov, N.E. Nifantiev, and A.I. Usov. 2002. Structure of a fucoidan from the brown seaweed Fucus evanescens C. Ag. Carbohydr. Res. 337:719-730.
16. Bilan, M.I., A.A. Grachev, N.E. Ustuzhanina, A.S. Shashkov, N.E. Nifantiev, and A.I. Usov. 2004. A highly regular fraction of a fucoidan from the brown seaweed Fucus distichus L. Carbohydr. Res. 339:511-517.
17. Black, W.A.P. 1954. The seasonal variation in the combined L-fucose content of the common British Laminariaceae and Fucaceae. J. Sci. Food Agri. 5:445-448.
18. Blondin, C., E. Fischer, C. Boisson-Vidal, M.D. Kazatchkine, and J. Jozefonvicz. 1994. Inhibition of complement activation by natural sulfated polysaccharides (Fucans) from brown seaweeds. Mol. Immunol. 31:247-253.
19. Boisson-Vidal, C., F. Zemani, G. Caligiuri et al. 2007. Neoangiogenesis induced by progenitor endothelial cells: Effect of fucoidan from marine algae. Cardiovasc. Hematol. Agents Med. Chem. 5:67-77.
20. Chargaff, E.F., F.W. Bancroft., and M. Stanley-Brown. 1936. Studies on the chemistry of blood clotting by substances of high molecular weight. J. Biol. Chem. 115:155-161.
21. Chattopadhyay, N., T. Ghosh, S. Sinha, K. Chattopadhyay, P. Karmakar, and B. Ray. 2010. Polysaccharides from Turbinaria conoides: Structural features and antioxidant capacity. Food Chem. 118:823-829.
22. Cherbut, C., V. Salvador, J.-L. Barry, F. Doulay, and J. Delort-Laval. 1991. Dietary fibers effect on intestinal transit in man: Involvement of their physico-chemical and fermentative properties. Food Hydrocoll. 5:15-22.
23. Chevolot, L., A. Foucault, F. Chaubet et al. 1999. Further data on the structure of brown seaweed fucans: Relationships with anticoagulant activity. Carbohydr. Res. 319:154-165.
24. Chevolot, L., B. Mulloy, J. Ratiskol, A. Foucault, and S. Colliec-Jouault. 2001. A disaccharide repeat unit is the major structure in fucoidans from two species of brown algae. Carbohydr. Res. 330:529-535.
25. Chizhov, A.O., A. Dell, H.R. Morris et al. 1999. A study of fucoidan from brown seaweed Chorda filum. Carbohydr. Res. 320:108-119.
26. Cho, Y.-S., W.-K. Jung, J.-A. Kim, I.-W. Choi, and S.-K. Kim. 2009. Beneficial effects of fucoidan on osteoblastic MG-63 cell differentiation. Food Chem. 116:990-994.
27. Cho, M.L., B.-Y. Lee, and S.-G. You. 2011. Relationship between oversulfation and conformation of low and high molecular weight fucoidans and evaluation of their in vitro anticancer activity. Molecules 16:291-297.
28. Choi, E.-M., A.-J. Kim, Y.-O. Kim, and J.-K. Hwang. 2005. Immunomodulating activity of arabinogalactan and fucoidan in vitro. J. Med. Food 8:446-453.
29. Chotigeat, W., S. Tongsupa, K. Supamataya, and A. Phongdara. 2004. Effect of fucoidan on disease resistance of black tiger shrimp. Aquaculture 233:23-30.
30. Church, F.C., I.B. Meade, and R.E. Treanor. 1989. Antithrombin activity of fucoidan. J. Biol. Chem. 264:3618-3623.
31. Cooper, R., C. Dragar, K. Elliot, J.H. Fitton, J. Godwin, and K. Thompson. 2002. GFS, a preparation of Tasmanian Undaria pinnatifida is associated with healing and inhibition of reactivation of herpes. BMC Complement. Altern. Med. 2:1-7.
32. Deux, J.F., A. Meddahi-Pellé, A.F. Le Blanche et al. 2002. Low molecular weight fucoidan prevents neointimal hyperplasia in rabbit iliac artery in-stent restenosis model. Arterioscler. Thromb. Vasc. Biol. 22:1604-1609.
33. Doh-ura, K., T. Kuge, M. Uomoto, K. Nishizawa, Y. Kawasaki, and M. Iha. 2007. Prophylactic effect of dietary seaweed fucoidan against enteral prion infection. Antimicrob. Agents Chemother. 51:2274-2277.
34. Elkins, R.M.H. 2001. Limu Moui: Prize Sea Plant of Tonga and the South Pacific. Pleasant Grove, UT: Woodland Publishing.
35. Evans, L.V., M. Simpson, and M.E. Callow. 1973. Sulphated polysaccharide synthesis in brown algae. Planta. 110:237-252.
36. Food and Drug Administration. 2012. Cosmetics-compliance and regulatory information. http://www.fda.gov/cosmetics/guidancecomplianceregulatoryinformation/ucm074201.htm (accessed on June 18, 2012).
37. Fitton, J.H. 2003. Brown marine algae: A survey of therapeutic potentials. Altern. Complement. Ther. 9:29-33.
38. Fitton, J.H., M. Irhimeh, and N. Falk. 2007. Macroalgal fucoidan extracts: A new opportunity for marine cosmetics. Cosmet. Toilet. 122:55-64.
39. Fujii, M., D.-X. Hou, and M. Nakamizo. 2005. Fucoidan-based health food. U.S. Patent 0129708 A1. http://www.google.com/patents/about/10_735_958_Fucoidan_based_health_food.html?id=pkiVAAAAEBAJ (accessed on June 18, 2012).
40. Fujimura, T., K. Tsukahara, S. Moriwaki, T. Kitahara, T. Sano, and Y. Takema. 2002. Treatment of human skin with an extract of Fucus vesiculosus changes its thickness and mechanical properties. J. Cosmet. Sci. 53:1-9.
41. Fujimura, T., K. Tsukahara, S. Moriwaki, T. Kitahara, and Y. Takema. 2000. Effects of natural product extracts on contraction and mechanical properties of fibroblast populated collagen gel. Biol. Pharm. Bull. 23:291-297.
42. Guimarães, M.A.M. and P.A.S. Mourão. 1997. Urinary excretion of sulfated polysaccharides administrated to Wistar rats suggests a renal permselectivity to these polymers based on molecular size. Biochim. Biophys. Acta 1335:161-172.
43. Hagiwara, H. 2010. Methods of extracting fucoidan. U.S. Patent 0056473 A1. http://www.google.com/patents/US20070087996 (accessed on June 18, 2012).
44. Hisatome, I., Y. Shirayoshi, H. Takeya, R. Teshima, and Y. Miki. 2010. Food/beverage and pharmaceutical composition for oral administration for improvement in acidic urine each comprising fucoidan as active ingredient. U.S. Patent 0048507 A1. http://www.google.com/patents/about/12_530_332_FOOD_BEVERAGE_AND_PHARMACEUTI.html?id=gUrNAAAAEBAJ (accessed on June 18, 2012).
45. Holtkamp, A.D., S. Kelly, R. Ulber, and S. Lang. 2009. Fucoidans and fucoidanases—Focus on techniques for molecular structure elucidation and modification of marine polysaccharides. Appl. Microbiol. Biotechnol. 82:1-11.
46. Honya, M., H. Mori, M. Anzai, Y. Araki, and K. Nisizawa. 1999. Monthly changes in the content of fucans, their constituent sugars and sulphate in cultured Laminaria japonica. Hydrobiology 398/399:411-416.
47. INCI Directory. 2012. International Nomenclature of Cosmetic Ingredients (INCI) Numbers. http://www.specialchem4cosmetics.com/services/inci/index.aspx (accessed on June 18, 2012).
48. Irhimeh, M.R., J.H. Fitton, and R.M. Lowenthal. 2007. Fucoidan ingestion increases the expression of CXCR4 on human CD34+ cells. Exp. Hematol. 35:989-994.
49. Irhimeh, M.R., J.H. Fitton, and R.M. Lowenthal. 2009. Pilot clinical study to evaluate the anticoagulant activity of fucoidan. Blood Coagul. Fibrinolysis 20:607-610.
50. Irhimeh, M.R., J.H. Fitton, R.M. Lowenthal, and P. Kongtawelert. 2005. A quantitative method to detect fucoidan in human plasma using a novel antibody. Methods Find. Exp. Clin. Pharmacol. 27:705-710.
51. Jiao, G., G. Yu., J. Zhang, and H.S. Ewart. 2011. Chemical structures and bioactivities of sulfated polysaccharides from marine algae. Mar. Drugs 9:196-223.
52. Juffrie, M., I. Rosalina, W. Damayanti, A. Djumhana, A. Rosalina, and H. Ahmad. 2006. The efficacy of fucoidan on gastric ulcer. Indones. J. Biotechnol. 11:908-913.
53. Jung, W.-K., Y. Athukoraka, Y.-J. Lee et al. 2007. Sulfated polysaccharide purified from Ecklonia cava accelerates antithrombin III-mediated plasma proteinase inhibition. J. Appl. Phycol. 19:425-430.
54. Kang, K.S., I.D. Kim, R.H. Kwon, and B.J. Ha. 2008. Undaria pinnatifida fucoidan extract protects against CCl4-induced oxidative stress. Biotechnol. Bioprocess Eng. 13:168-173.
55. Khan, M.N.A., M.-C. Lee, J.-Y. Kang, N.G. Park, H. Fujii, and Y.-K. Hong. 2008. Effects of the brown seaweed Undaria pinnatifida on erythematous inflammation assessed using digital photo analysis. Phytother. Res. 22:634-639.
56. Kim, S.H., D.S. Choi, Y. Athukorala, Y.-J. Jeon, M. Senevirathne, and C.K. Rha. 2007. Antioxidant activity of sulfated polysaccharides isolated from Sargassum fulvellum. J. Food Sci. Nutr. 12:65-73.
57. Koyanagi, S., N. Tanigawa, H. Nakagawa, S. Soeda, and H. Shimeno. 2003. Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem. Pharmacol. 65:173-179.
58. Kusaykin, M., I. Bakunina, V. Sova et al. 2008. Structure, biological activity, and enzymatic transformation of fucoidans from the brown seaweeds. Biotechnol. J. 3:904-915.
59. Kylin, H. 1913. Zur biochemie der meersalgen. Z. Physiol. Chem. 83:171-197.
60. Laurienzo, P. 2010. Marine polysaccharides in pharmaceutical applications: An overview. Mar. Drugs 8:2435-2465.
61. Li, B., F. Lu, X. Wei, and R. Zhao. 2008. Fucoidan: Structure and bioactivity. Molecules 13:1671-1695.
62. Li B., X.J. Wei, J.L. Sun, and S.Y. Xu. 2006. Structural investigation of a fucoidan containing a fucose-free core from the brown seaweed, Hizikia fusiforme. Carbohydr. Res. 341:1135-1146.
63. Mabeau, S. and B. Kloareg. 1987. Isolation and analysis of the cell walls of brown algae: Fucus spiralis, F. Ceranoides, F. vesiculosus, F. serratus, Bifurcaria and Laminaria digitata. J. Exp. Bot. 38:1573-1580.
64. Mabeau, S., B. Kloareg, and J.P. Joseleau. 1990. Fractionation and analysis of fucans from brown algae. Phytochemistry 29:2441-2445.
65. Merkle, R.K. and I. Poppe. 1994. Carbohydrate composition analysis of glycoconjugates by gas-liquid chromatography/mass spectrometry. Methods Enzymol. 230:1-15.
66. Mian, A.J. and E. Percival. 1973. Carbohydrates of the brown seaweeds Himanthalia lorea, Bifurcaria bifurcata, and Padina pavonia: Part I. Extraction and fractionation. Carbohydr. Res. 26:133-146.
67. Mimeault, M. and S.K. Batra. 2011. Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy. Chin. Med. 6:1-19.
68. Mizuno, M., Y. Nishitani, T. Tanoue et al. 2009. Quantification and localization of fucoidan in Laminaria japonica using novel antibody. Biosci. Biotechnol. Biochem. 73:335-338.
69. Mizutani, S., S. Deguchi, E. Kobayashi, E. Nishiyama, H. Sagawa, and I. Kato. 2006. Fucoidan-containing cosmetics. U.S. Patent 0093566. http://www.google.co.il/patents/about/7678368_Fucoidan_containing_cosmetics.html?id=nanNAAAAEBAJ (accessed on June 18, 2012).
70. Moon, H.J., S.H. Lee, M.J. Ku et al. 2009. Fucoidan inhibits UVB-induced MMP-1 promoter expression and down regulation of type I procollagen synthesis in human skin fibroblasts. Eur. J. Dermatol. 19:129-134.
71. Moon, H.J., S.R. Lee, S.N. Shim et al. 2008. Fucoidan inhibits UVB-induced MMP-1 expression in human skin fibroblasts. Biol. Pharm. Bull. 31:284-289.
72. Mower, T.E. 2007. Sports drink concentrate. U.S. Patent 0020358. http://www.google.com/patents/about/SPORTS_DRINK_CONCENTRATE.html?id=A7-XAAAAEBAJ (accessed on June 18, 2012).
73. Mower, T.E. 2010. Fucoidan compositions and methods for dietary and nutritional supplements. U.S. Patent 0330211 A1. http://www.google.com/patents/US7749545 (accessed on June 18, 2012).
74. Mulloy, B., A.C. Ribeiro, A.P. Alves, R.P. Vieira, and P.A.S. Mourão. 1994. Sulfated fucans from echinoderms have a regular tetrasaccharide repeating unit defined by specific patterns of sulfation at the 0-2 and 0-4 positions. J. Biol. Chem. 269:22113-22123.
75. Nagaoka, M., H. Shibata, I. Kimura-Takagi et al. 1999. Structural study of fucoidan from Cladosiphon okamuranus Tokida. Glycoconj. J. 16:19-26.
76. Nagumo, T. and T. Nishino. 1996. Fucan sulfates and their anticoagulant activities. In Polysaccharides in Medicinal Applications, ed. S. Dumitriu, pp. 545-574. New York: Marcel Dekker.
77. Nakazato, K., H. Takada, M. Iha, and T. Nagamine. 2010. Attenuation of N-nitrosodiethylamine-induced liver fibrosis by high-molecular-weight fucoidan derived from Cladosiphon okamuranus. J. Gastroenterol. Hepatol. 25:1692-1701.
78. Nishino, T., T. Nagumo, H. Kiyohara, and H. Yamada. 1991. Structural characterization of a new anticoagulant fucan sulfate from the brown seaweed Ecklonia kurome. Carbohydr. Res. 211:77-90.
79. Nishino, T., C. Nishioka, H. Ura, and T. Nagumo. 1994. Isolation and partial characterization of a novel amino sugar-containing fucan sulfate from commercial Fucus vesiculosus fucoidan. Carbohydr. Res. 255:213-224.
80. O’Leary, R., M. Rerek., and E. J. Wood. 2004. Fucoidan modulates the effects of transforming growth factor (TGF)-β1 on fibroblast proliferation and wound repopulation in in vitro models of dermal wound repair. Biol. Pharm. Bull. 27:266-270.
81. Oehninger, S., G.F. Clark, D. Fulgham et al. 1992. Effect of fucoidin on human sperm-zona pellucida interactions. J. Androl. 13:519-525.
82. Oh, K.D. 2009. Degradation of brown alga-derived fucoidan. U.S. Patent 0270607. http://www.patentstorm.us/applications/20090270607/description.html (accessed on June 18, 2012).
83. Okinaga, S. 2000. Shedding of Herpes simplex virus type-1 into tears and saliva in healthy Japanese adults. Kurume Med. J. 47:273-277.
84. Ozawa, T., J. Yamamoto, T. Yamagishi, N. Yamazaki, and M. Nishizawa. 2006. Two fucoidans in the holdfast of cultivated Laminaria japonica. J. Nat. Med. 60:236-239.
85. Park, H.S., G.-Y. Kim, T.-J. Nam, N.D. Kim, and Y.H. Choi. 2011. Antiproliferative activity of fucoidan was associated with the induction of apoptosis and autophagy in AGS gastric cancer cells. J. Food Sci. 76:77-83.
86. Ponce, N.M.A., C.A. Pujol, E.B. Damonte, M.L. Flores, and C.A. Stortz. 2003. Fucoidans from the brown seaweed Adenocystis utricularis: Extraction methods, antiviral activity and structural studies. Carbohydr. Res. 338:153-165.
87. Prasad, S., D. Lillicrap, A. Labelle et al. 2008. Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A. Blood 111:672-679.
88. Raghavendran, H.R.B., P. Srinivasan, and S. Rekha. 2011. Immunomodulatory activity of fucoidan against aspirin-induced gastric mucosal damage in rats. Int. Immunopharmacol. 11:157-163.
89. Ranatunga, 2007. Functional nutraceutical beverage: Youth juice. http://www.checkthescience.com/youthjuice.html (accessed on June 18, 2012).
90. Rhee, K.H. and K.H. Lee. 2011. Protective effects of fucoidan against γ-radiation-induced damage of blood cells. Arch. Pharm. Res. 34:645-651.
91. Rocha, H.A.O, C.R.C. Ranco, E.S. Trindade et al. 2001. A fucan from the brown seaweed Spatoglossum schröederi inhibits Chinese hamster ovary cell adhesion to several extracellular matrix proteins. Braz. J. Med. Biol. Res. 34:621-626.
92. Sakai, T., T Kawai., and I. Kato. 2004. Isolation and characterization of a fucoidan-degrading marine bacteria strain and its fucoidanase. Mar. Biotechnol. 6:335-346.
93. Sakai, T., H. Kimura, and I. Kato. 2002. A marine strain of flavobacteriaceae utilizes brown seaweed fucoidan. Mar. Biotechnol. 4:399-404.
94. Sakai, T., H. Kimura, K. Kojima et al. 2003. Sulfated fucogalactan. U.S. Patent 6590097 B1. http://www.google.com/patents/US6590097
95. Salyers, A.A., J.R. Vercellotti, S.E.H. West, and T.D. Wilkins. 1977. Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon. Appl. Environ. Microbiol. 33:319-322.
96. Sardy, M. 2009. Role of matrix metalloproteinases in skin ageing. Connect. Tissue Res. 50: 132-138.
97. Schumacher, M., M. Kelkel, M. Dicato, and M. Diederich. 2011. Gold from the sea: Marine compounds as inhibitors of the hallmarks of cancer. Biotechnol. Adv. 29:531-547.
98. Senanayake, S.P.J.N., N. Ahmed, and J. Fichtali. 2011. Nutraceuticals and bioactives from marine algae. In Handbook of Seafood Quality, Safety and Health Applications, eds. C. Alasalvar, K. Miyashita, F. Shahidi, and U. Wanasundara, pp. 455-463. West Sussex, U.K.: Blackwell Publishing Ltd.
99. Senni, K., F. Gueniche, and A. Foucault-Bertaud et al. 2006. Fucoidan a sulfated polysaccharide from brown algae is a potent modulator of connective tissue proteolysis. Arch. Biochem. Biophys. 445:56-64.
100. Sezer, A.D., E. Cevher, F. Hatipoğlu, Z. Oğurtan, A.L. Bas¸, and J. Akbuğa. 2008a. Preparation of fucoidan-chitosan hydrogel and its application as burn healing accelerator on rabbits. Biol. Pharm. Bull. 31:2326-2333.
101. Sezer, A.D., E. Cevher, F. Hatipoğlu, Z. Oğurtan, A.L. Bas¸, and J. Akbuğa. 2008b. The use of fucosphere in the treatment of dermal burns in rabbits. Eur. J. Pharm. Biopharm. 69:189-198.
102. Shaklee, P.N., J. Bahr-Davidson, S. Prasad, and K. Johnson. 2010. Methods for fucoidan purification from seaweed extracts. U.S. Patent 0144667. http://www.google.com/patents/US20100144667 (accessed on June 18, 2012).
103. Shanmugam, M. and K.H. Mody. 2000. Heparinoid-active sulphated polysaccharides from marine algae as potential blood anticoagulant agent. Curr. Sci. 79:1672-1683.
104. Shibata, H., I. Kimura-Takagi, M. Nagaoka et al. 2000. Properties of fucoidan from Cladosiphon okamuranus tokida in gastric mucosal protection. BioFactors 11:235-245.
105. Skriptsova, A.V., N.M. Shevchenko, T.N. Zvyagintseva, and T.I. Imbs. 2010. Monthly changes in the content and monosaccharide composition of fucoidan from Undaria pinnatifida (Laminariales, Phaeophyta). J. Appl. Phycol. 22:79-86.
106. Soeda, S., S. Ishida, H. Shimeno, and A. Nagamatsu. 1994. Inhibitory effect of oversulfated fucoidan on invasion through reconstituted basement membrane by Murine Lewis lung carcinoma. Jpn. J. Cancer Res. 85:1144-1150.
107. Springer, G.F., H. A. Wurzel., G.M. Mcneal Jr, N.J. Ansell, and M.F. Doughty. 1957. Isolation of anticoagulant fractions from crude fucoidan. Proc. Soc. Exp. Biol. Med. 94:404-409.
108. Teixeira, M.M. and P.G. Hellewell. 1997. The effect of the selectin binding polysaccharide fucoidin on eosinophil recruitment in vivo. Br. J. Pharmacol. 120:1059-1066.
109. Thomes, P., M. Rajendran, B. Pasanban, and R. Rengasamy. 2010. Cardioprotective activity of Cladosiphon okamuranus fucoidan against isoproterenol induced myocardial infarction in rats. Phytomedicine 18:52-57.
110. Tissot, B. and R. Daniel. 2003. Biological properties of sulfated fucans: The potent inhibiting activity of algal fucoidan against the human complement system. Glycobiology 13:29-31.
111. Usov, A.I. and M.I. Bilan. 2009. Fucoidans-sulfated polysaccharides of brown algae. Russ. Chem. Rev. 78:785-799.
112. Usov, A.I., G.P. Smirnova, and N.G. Klochkova. 2001. Polysaccharides of algae: 55. Polysaccharide composition of several brown algae from Kamchatka. Russ. J. Bioorg. Chem. 27:395-399.
113. Usov, A.I., G.P. Smirnova, and N.G. Klochkova. 2005. Polysaccharides of algae: 58. The polysaccharide composition of the Pacific brown alga Alaria fistulosa P. et R. (Alariaceae, Laminariales). Russ. Chem. Bull. Int. Ed. 54:1282-1286.
114. Venugopal, V. 2011. Seaweed, microalgae, and their polysaccharides: Food applications. In Marine Polysaccharides: Food Applications, pp. 191-236. CRC Press, Boca Raton, FL.
115. Vilela-Silva, A.C.E.S., A.P. Alves, A.P. Valente, V.D. Vacquier, and P.A.S. Mourão. 1999. Structure of the sulfated α-l-fucan from the egg jelly coat of the sea urchin Strongylocentrotus franciscanus: Patterns of preferential 2-0- and 4-0-sulfation determine sperm cell recognition. Glycobiology 9:927-933.
116. Vilela-Silva, A.C.E.S., M.O. Castro, A.P. Valente, C.H. Biermann, and P.A.S. Mourão. 2002. Sulfated fucans from the egg jellies of the closely related sea urchins Strongylocentrotus droebachiensis and Strongylocentrotus pallidus ensure species-specific fertilization. J. Biol. Chem. 277:379-387.
117. Vitarich Laboratories, 2004. Limu plus vs. original limu. http://www.mlmwatchdog.com/ComparisonLimuResearch.pdf (accessed on June 18, 2012).
118. Wang, J., L. Liu, Q. Zhang, Z. Zhang, H. Qi, and P. Li. 2009. Synthesized oversulphated, acetylated and benzoylated derivatives of fucoidan extracted from Laminaria japonica and their potential antioxidant activity in vitro. Food Chem. 114:1285-1290.
119. Wang, J., Q. Zhang, Z. Zhang, and Z. Li. 2008. Antioxidant activity of sulfated polysaccharide fractions extracted from Laminaria japonica. Int. J. Biol. Macromol. 42:127-132.
120. Wijesinghe, W.A.J.P., Y. Athukorala., and Y.-J. Jeon. 2011. The effect of anticoagulative sulfated polysaccharide purified from enzyme-assistant extract of a brown seaweed Ecklonia cava on Wistar rats. Carbohydr. Polym. 86:917-921.
121. Xue, C.-H., Y. Fang, H. Lin et al. 2001. Chemical characters and antioxidative properties of sulfated polysaccharides from Laminaria japonica. J. Appl. Phycol. 13:67-70.
122. Yuan, Y.V. 2007. Antioxidants from edible seaweeds. In Antioxidant Measurement and Applications, eds. F. Shahidi and C.-T. Ho, pp. 268-301. ACS symposium series (Vol. 956). Washington, DC: ACS.
123. Yuan, Y.V. 2008. Marine algal constituents. In Marine Nutraceuticals and Functional Foods, eds. C. Barrow, and F. Shahidi, pp. 259-296. Boca Raton, FL: CRC Press.
124. Zhang, Q., P. Yu, Z. Li, H. Zhang, Z. Xu, and P. Li. 2003. Antioxidant activities of sulfated polysaccharide fractions from Porphyra haitanesis. J. Appl. Phycol. 15:305-310.
125. Zvyagintseva, T.N., N.M. Shevchenko, I.V. Nazarova, A.S. Scobun, P.A. Luk’yanov, and L.A. Elyakova. 2000. Inhibition of complement activation by water-soluble polysaccharides of some far-eastern brown seaweeds. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 126:209-215.